Lilly settles Mississippi lawsuit for more than $18 million
Eli Lilly & Co. will pay $18.5 million to end Mississippi’s case against it for promotional claims related to the anti-psychotic drug Zyprexa, according to an announcement made by state Attorney General Jim Hood at the end of January.
Register for free to listen to this article
Listen with Speechify
0:00
5:00
JACKSON, Miss.—Eli Lilly & Co. will pay $18.5 million toend Mississippi's case against it for promotional claims related to theanti-psychotic drug Zyprexa, according to an announcement made by stateAttorney General Jim Hood at the end of January. Under the settlement, Lillyagreed to curb marketing activities and payments to healthcare professionalsfor non-approved uses Zyprexa, which is approved for the treatment of bipolardisorders. Lilly had been accused of promoting the drug for any kind ofdepression. In the 23-page settlement, Lilly did not admit that it violated anystate consumer protection laws and said it had not committed any "liability,fault or wrongdoing." The agreement with the Attorney General's Office does notprotect Lilly from criminal allegations.
